ResearcherTulane UniversityNo recent work listed

Lizheng Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7827-6766; OpenAlex author ID A5069523303. Sources: OpenAlex.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2020: 1 paper

Papers 1

Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. First author DOI 10.6004/jnccn.2020.7587 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bin Yan Wu · 1 shared paper, 2020 · strength 0.24
- Paper Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. DOI 10.6004/jnccn.2020.7587 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.